Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (141-150 of 868) with videos related to

Pageof 87
Sort By:
Nature Reviews. Clinical Oncology|September 30, 2009
Hematology: Thalidomide maintenance in multiple myelomaJacob P Laubach, Paul G Richardson, Kenneth C Anderson
Frontiers in Immunology|August 28, 2018
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1Yu-Tzu Tai, Shih-Feng Cho, Kenneth C Anderson
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Proteasome inhibition in the treatment of cancerPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.
British Journal of Haematology|January 18, 2006
Novel therapeutic strategies targeting growth factor signalling cascades in multiple myelomaHiroshi Yasui, Teru Hideshima, Paul G Richardson, et al.
Expert Review of Anticancer Therapy|April 13, 2007
Targeting the vascular endothelial growth factor pathway in the treatment of multiple myelomaKlaus Podar, Paul G Richardson, Dharminder Chauhan, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Telomerase inhibitors as anticancer therapyMasaharu Akiyama, Teru Hideshima, Nikhil C Munshi, et al.
Oncology (Williston Park, N.Y.)|March 2, 2006
New treatments for multiple myelomaPaul G Richardson, Robert Schlossman, Teru Hideshima, et al.
Cancer Journal (Sudbury, Mass.)|March 16, 2002
Arsenic trioxide in multiple myeloma: rationale and future directionsKenneth C Anderson, Lawrence H Boise, Robert Louie, et al.
Therapeutics and Clinical Risk Management|August 30, 2008
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myelomaTeru Hideshima, Noopur Raje, Paul G Richardson, et al.
European Journal of Haematology|October 15, 2010
Emerging therapies for the treatment of relapsed or refractory multiple myelomaMeletios A Dimopoulos, Jesus F San-Miguel, Kenneth C Anderson
Pageof 87

Showing results (141-150 of 868) with videos related to

Sort By:
Pageof 87
Nature Reviews. Clinical Oncology|September 30, 2009
Hematology: Thalidomide maintenance in multiple myelomaJacob P Laubach, Paul G Richardson, Kenneth C Anderson
Frontiers in Immunology|August 28, 2018
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1Yu-Tzu Tai, Shih-Feng Cho, Kenneth C Anderson
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Proteasome inhibition in the treatment of cancerPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.
British Journal of Haematology|January 18, 2006
Novel therapeutic strategies targeting growth factor signalling cascades in multiple myelomaHiroshi Yasui, Teru Hideshima, Paul G Richardson, et al.
Expert Review of Anticancer Therapy|April 13, 2007
Targeting the vascular endothelial growth factor pathway in the treatment of multiple myelomaKlaus Podar, Paul G Richardson, Dharminder Chauhan, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Telomerase inhibitors as anticancer therapyMasaharu Akiyama, Teru Hideshima, Nikhil C Munshi, et al.
Oncology (Williston Park, N.Y.)|March 2, 2006
New treatments for multiple myelomaPaul G Richardson, Robert Schlossman, Teru Hideshima, et al.
Cancer Journal (Sudbury, Mass.)|March 16, 2002
Arsenic trioxide in multiple myeloma: rationale and future directionsKenneth C Anderson, Lawrence H Boise, Robert Louie, et al.
Therapeutics and Clinical Risk Management|August 30, 2008
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myelomaTeru Hideshima, Noopur Raje, Paul G Richardson, et al.
European Journal of Haematology|October 15, 2010
Emerging therapies for the treatment of relapsed or refractory multiple myelomaMeletios A Dimopoulos, Jesus F San-Miguel, Kenneth C Anderson
Pageof 87